IP Library Granted Patent US 10,485,702
Granted Patent B2
US 10,485,702 · App. 16/003,919 · Granted Nov 26, 2019

System and method for treating an ocular disorder

Inventors: Olav B. Bergheim (Laguna Hills, CA); Morteza Gharib (Altadena, CA); Richard A. Hill (Irvine, CA)
Assignee: GLAUKOS CORPORATION
A61F9/00781A61F9/007A61F9/0017A61K9/0051A61M27/002A61F2009/00891A61F2250/0067A61M2210/0612Y10S623/905
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,485,702
App. No.
16/003,919
Granted
Nov 26, 2019
Kind
B2
Abstract

Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.

Claims (42)

1. A method of treating glaucoma comprising:

forming an incision in a cornea of an eye;

inserting a delivery applicator through the incision in the cornea and across at least a portion of an anterior chamber of the eye in an ab interno manner under gonioscopic guidance, the delivery applicator comprising an elongate member having a distal end portion configured to retain an implant therein, the distal end portion comprising a cutting member configured to penetrate a trabecular meshwork of the eye for receipt of the implant in Schlemm's canal;

penetrating the trabecular meshwork using the cutting member of the delivery applicator;

guiding the implant into Schlemm's canal such that a distal section of the implant extends along a length of Schlemm's canal and such that a proximal end of the implant is positioned in the anterior chamber; and

removing the delivery applicator from the eye,

wherein the implant comprises flexible material that is at curved along its distal section,

wherein the implant is sized and shaped so as to slide in place in Schlemm's canal without undue suturing, and

wherein the implant has at least one opening positioned along its distal section.

2. The method of claim 1 , wherein the incision is a self-sealing incision.

3. The method of claim 1 , wherein implant is made of a biocompatible, elastic material.

4. The method of claim 1 , wherein the implant has a generally tubular shape.

5. The method of claim 1 , wherein the implant comprises a one-way valve.

6. The method of claim 1 , wherein the implant comprises one or more retention features.

7. A method of treating glaucoma comprising:

forming an incision in a cornea of an eye;

inserting a delivery applicator through the incision in the cornea and across at least a portion of an anterior chamber of the eye, the delivery applicator comprising an elongate member having a distal end portion configured to retain an elongated seton therein, the delivery applicator being sharpened;

penetrating a trabecular meshwork of the eye using the delivery applicator;

guiding the elongated seton into Schlemm's canal of the eye such that a distal section of the elongated seton extends along a length of Schlemm's canal and such that an inlet section of the elongated seton is positioned in the anterior chamber; and

removing the delivery applicator from the eye,

wherein the distal section of the elongated seton is curved at an angle between 30 degrees and 150 degrees with reference to the inlet section of the elongated seton, and

wherein the elongated seton has at least one opening positioned along its distal section.

8. The method of claim 7 , wherein the incision is a self-sealing incision.

9. The method of claim 7 , wherein seton is made of a biocompatible, elastic material.

10. The method of claim 7 , wherein the seton has a generally tubular shape.

11. The method of claim 7 , wherein the seton comprises a one-way valve.

12. The method of claim 7 , wherein the seton comprises one or more retention features.

13. The method of claim 7 , wherein the seton comprises an opening along its distal section.

14. A method of treating glaucoma comprising:

forming an incision in a cornea of an eye;

inserting a delivery applicator through the incision in the cornea and across at least a portion of an anterior chamber of the eye in an ab interno manner under gonioscopic guidance, the delivery applicator comprising an elongate member having a distal end portion configured to retain an implant therein, the distal end portion comprising a cutting member configured to form an opening in the trabecular meshwork of the eye for receipt of the implant;

forming an opening in a trabecular meshwork using the cutting member of the delivery applicator;

delivering the implant out of the elongate member of the delivery applicator such that a distal section of the implant is positioned in Schlemm's canal of the eye so as to extend along a length of Schlemm's canal and such that a proximal end of the implant is positioned in the anterior chamber; and

removing the delivery applicator from the eye,

wherein the implant is made of relatively soft material that is at least somewhat curved at its distal section to fit into and along Schlemm's canal,

wherein the implant is sized and shaped so as to stabilize the implant in place without undue suturing, and

wherein the implant has at least one opening positioned along its distal section.

15. The method of claim 14 , wherein the incision is a self-sealing incision.

16. The method of claim 14 , wherein implant is made of a biocompatible, elastic material.

17. The method of claim 14 , wherein the implant has a generally tubular shape.

18. The method of claim 14 , wherein the implant comprises a one-way valve.

19. The method of claim 14 , wherein the implant comprises one or more retention features.

Continuity (6)
Continuation 12914940 · Oct 28, 2010
Continuation 12437482 · May 7, 2009
Continuation 11124440 · May 6, 2005
Continuation 10395631 · Mar 21, 2003
Continuation 09549350 · Apr 14, 2000
Related Publication 20190046355A1 · Feb 14, 2019
Cited By (19)
US 1,137,672 US 12,186,237 US 12,201,555 US 12,201,557 US 12,208,034 US 12,226,308 US 12,279,822 US 12,343,288 US 12,376,989 US 12,414,798 US 12,419,783 US 12,427,057 US 12,478,503 US 12,478,504 US 12,514,750 US 12,575,972 US 12,599,497 US 12,667,486 US 12,702,294